antibodies hiv- vaccine development therapy 
despite years study hiv- vaccine recently little hope protective immunization renewed optimism area research comes part results recent vaccine trial use single-cell antibody-cloning techniques uncovered naturally arising broad potent hiv--neutralizing antibodies bnabs antibodies can protect infection suppress established hiv- infection animal models finding antibodies develop fraction infected individuals supports idea new approaches vaccination might developed adapting natural immune strategies structure-based immunogen design moreover success passive immunotherapy small-animal models suggests bnabs may become valuable addition armamentarium drugs work hiv- 
